Literature DB >> 25656833

Urinary early kidney injury molecules in children with beta-thalassemia major.

Velat Şen1, Aydın Ece, Ünal Uluca, Murat Söker, Ali Güneş, İbrahim Kaplan, İlhan Tan, Servet Yel, Nuriye Mete, Cahit Sahin.   

Abstract

BACKGROUND: The aim of this study was to investigate novel urinary biomarkers including N-acetyl-β-D-glucosaminidase (NAG), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and liver-type fatty acid binding protein (L-FABP) in children with β-thalassemia major (β-TM).
MATERIALS AND METHODS: Totally, 52 patients (29 boys, 23 girls) with β-TM and 29 healthy controls (3-17 years) were included. Various demographic characteristics and blood transfusions/year, disease duration, and chelation therapy were recorded. Serum urea, creatinine, electrolytes, and ferritin and urinary creatinine, protein, calcium, phosphorus, sodium, potassium, and uric acid in first morning urine samples were measured and estimated glomerular filtration rate (eGFR) was calculated. Routine serum and urinary biochemical variables, urinary NAG to Creatinine (U(NAG/Cr)), U(NGAL/Cr), U(KIM-1/Cr), and U(L-FABP/Cr) ratios were determined.
RESULTS: Patients had similar mean serum urea, creatinine and eGFR levels compared with controls (p > 0.05 for all). The mean urinary protein to creatinine (U(Protein/Cr)) ratio was significantly higher in patients compared to the healthy subjects (0.13 ± 0.09 mg/mg and 0.07 ± 0.04 mg/mg, respectively; p < 0.001). Significantly increased U(NAG/Cr) (0.48 ± 0.58 vs. 0.23 ± 0.16, p = 0.026) and U(NGAL/Cr) (22.1 ± 18.5 vs. 11.5 ± 6.17, p = 0.01) ratios were found in β-TM patients compared with healthy controls. However, no differences were found in serum and urinary electrolytes or U(KIM-1/Cr) and U(L-FABP/Cr) ratios between patients and controls (p > 0.05). Significant correlations were found between urinary biomarkers and urinary electrolytes (p < 0.05).
CONCLUSIONS: Our results suggest that urinary NAG and NGAL may be considered to be reliable markers to monitor renal injury in β-TM patients.

Entities:  

Keywords:  Early molecule; FABP; KIM-1; NAG; NGAL; Thalassemia; kidney injury

Mesh:

Substances:

Year:  2015        PMID: 25656833     DOI: 10.3109/0886022X.2015.1007871

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients.

Authors:  Mozhgan Hashemieh; Mitra Radfar; Azita Azarkeivan; Seyed Mohammad Taghi Hosseini Tabatabaei; Sedigheh Nikbakht; Mehdi Yaseri; Kourosh Sheibani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

2.  Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major.

Authors:  Asmaa A Mahmoud; Doaa M Elian; Nahla Ms Abd El Hady; Heba M Abdallah; Shimaa Abdelsattar; Fatma O Khalil; Sameh A Abd El Naby
Journal:  Children (Basel)       Date:  2021-02-03

3.  Renal function in β-thalassemia major patients treated with two different iron-chelation regimes.

Authors:  Osama Tanous; Yossi Azulay; Raphael Halevy; Tal Dujovny; Neta Swartz; Raul Colodner; Ariel Koren; Carina Levin
Journal:  BMC Nephrol       Date:  2021-12-20       Impact factor: 2.388

4.  Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia.

Authors:  Mohammad G Shaalan; Meaad K Hassan; Hamid J Al-Shanoof; Lamia M Al Naama
Journal:  Cureus       Date:  2022-09-15

5.  Comparing different markers of tubular dysfunction in transfusion-dependent thalassemia patients.

Authors:  Ilham Youssry; Samuel Makar; Khalil Abdelkhalek; Dina Hisham; Happy Sawires
Journal:  Int Urol Nephrol       Date:  2021-06-24       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.